Kicker Ventures — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Swing TherapeuticsinJun 2022Acquired
Digital therapeutics developer behind Stanza, an FDA-authorized smartphone behavioral therapy for fibromyalgia symptoms.
BiotechHealthtechSan Francisco, US
Michael Rosenbluth(Executive Officer, Director)
BoardAndrew Firlik(Director)inZack Lynch(Director)inCorey McCann(Director)
PartnerMasashi Kiyomine· solo GP
Co-investorsAlumni VenturesAME Cloud VenturesAsahi Kasei Corporate VenturesGaingelsJAZZ Venture PartnersMana Ventures+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




__Twitter.png)

